Showing results (881-890 of 1,297) with videos related to

Sort By:
Pageof 130
Virchows Archiv : an International Journal of Pathology|May 5, 2022
Acellular mucin in lymph nodes isolated from treatment-naïve colorectal cancer resections: a clinicopathologic analysis of 16 casesJames E Lapinski, Alok A Khorana, Lisa Rybicki, et al.
Radiology|May 27, 2016
Limited Hospital Variation in the Use and Yield of CT for Pulmonary Embolism in Patients Undergoing Total Hip or Total Knee Replacement SurgeryKanako K Kumamaru, Hiraku Kumamaru, Brian T Bateman, et al.
Human Heredity|November 19, 2002
The distribution of long range admixture linkage disequilibrium in an African-American populationBenjamin A Rybicki, Sudha K Iyengar, Trent Harris, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 29, 2003
Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinomaThomas W Rice, Eugene H Blackstone, David J Adelstein, et al.
Science (New York, N.Y.)|August 3, 2019
A three-dimensional map of the Milky Way using classical Cepheid variable starsDorota M Skowron, Jan Skowron, Przemek Mróz, et al.
American Journal of Human Genetics|January 4, 2011
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probandsMin-Han Tan, Jessica Mester, Charissa Peterson, et al.
Leukemia & Lymphoma|February 15, 2011
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphomaBrian T Hill, Lisa Rybicki, Stephen Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Growth of Plasmodium falciparum in human erythrocytes containing abnormal membrane proteinsS Schulman, E F Roth, B Cheng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2011
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT)Nelli Bejanyan, Brian J Bolwell, Aleksandr Lazaryan, et al.
Hematology/Oncology and Stem Cell Therapy|July 18, 2015
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancerBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Pageof 130